Papers

1

Total Citations

46

H-Index

1

About

Dr. Jonathan Bones is a leading figure in biopharmaceutical analysis, with a primary focus on the characterization of therapeutic proteins, particularly monoclonal antibodies (mAbs). His major contributions lie in the development of high-throughput, automated analytical platforms that accelerate the critical quality attribute (CQA) profiling of these complex drugs. Notably, his pioneering work on an automated robotic platform for rapid oligosaccharide analysis directly from cell culture—a paper that has garnered 46 citations—revolutionized the speed and efficiency of glycosylation analysis. This innovation enables real-time monitoring of product quality during manufacturing, significantly impacting the bioprocessing industry. Dr. Bones’ research bridges the gap between advanced separation science and practical biomanufacturing needs, establishing him as a key innovator in ensuring the safety and efficacy of next-generation biologics. His work continues to shape how researchers and manufacturers approach the analytical challenges of complex protein therapeutics.

Research Focus

Key Achievements

1
H-Index
1
Papers
46
Total Citations
46
Avg Citations/Paper
🏆 Most Cited Paper
An automated robotic platform for rapid profiling oligosaccharide analysis of monoclonal antibodies directly from cell culture
46 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: National Institute for Bioprocessing Research and Training

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago